These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28618859)

  • 1. Sitagliptin Attenuates Endothelial Dysfunction of Zucker Diabetic Fatty Rats: Implication of the Antiperoxynitrite and Autophagy.
    Wang H; Zhou Y; Guo Z; Dong Y; Xu J; Huang H; Liu H; Wang W
    J Cardiovasc Pharmacol Ther; 2018 Jan; 23(1):66-78. PubMed ID: 28618859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type 2 diabetes severely impairs structural and functional adaptation of rat resistance arteries to chronic changes in blood flow.
    Belin de Chantemèle EJ; Vessières E; Guihot AL; Toutain B; Maquignau M; Loufrani L; Henrion D
    Cardiovasc Res; 2009 Mar; 81(4):788-96. PubMed ID: 19050009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progression of coronary and mesenteric vascular dysfunction in Zucker obese and Zucker diabetic fatty rats.
    Oltman CL; Richou LL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
    Am J Physiol Heart Circ Physiol; 2006 Oct; 291(4):H1780-7. PubMed ID: 16714356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic treatment restores adiponectin serum levels and APPL1 expression, but does not improve adiponectin-induced vasodilation and endothelial dysfunction in Zucker diabetic fatty rats.
    Schmid PM; Resch M; Schach C; Birner C; Riegger GA; Luchner A; Endemann DH
    Cardiovasc Diabetol; 2013 Mar; 12():46. PubMed ID: 23497197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosiglitazone reverses endothelial dysfunction but not remodeling of femoral artery in Zucker diabetic fatty rats.
    Lu X; Guo X; Karathanasis SK; Zimmerman KM; Onyia JE; Peterson RG; Kassab GS
    Cardiovasc Diabetol; 2010 May; 9():19. PubMed ID: 20482873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular lipotoxicity: endothelial dysfunction via fatty-acid-induced reactive oxygen species overproduction in obese Zucker diabetic fatty rats.
    Chinen I; Shimabukuro M; Yamakawa K; Higa N; Matsuzaki T; Noguchi K; Ueda S; Sakanashi M; Takasu N
    Endocrinology; 2007 Jan; 148(1):160-5. PubMed ID: 17023526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lycopene attenuates endothelial dysfunction in streptozotocin-induced diabetic rats by reducing oxidative stress.
    Zhu J; Wang CG; Xu YG
    Pharm Biol; 2011 Nov; 49(11):1144-9. PubMed ID: 21517710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 protects against endothelial dysfunction induced by high glucose levels in rats.
    Qian LB; Wang HP; Qiu WL; Huang H; Bruce IC; Xia Q
    Vascul Pharmacol; 2006 Dec; 45(6):374-82. PubMed ID: 16837248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress.
    Qian LB; Wang HP; Chen Y; Chen FX; Ma YY; Bruce IC; Xia Q
    Pharmacol Res; 2010 Apr; 61(4):281-7. PubMed ID: 19892019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2-derived prostanoids and oxidative stress additionally reduce endothelium-mediated relaxation in old type 2 diabetic rats.
    Vessières E; Guihot AL; Toutain B; Maquigneau M; Fassot C; Loufrani L; Henrion D
    PLoS One; 2013; 8(7):e68217. PubMed ID: 23874545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 3,4-dihydroxyacetophenone on endothelial dysfunction in streptozotocin-induced rats with type 2 diabetes.
    Liu C; Sun J; Xue F; Yi Y; Han A
    J Cardiovasc Pharmacol; 2015 Jan; 65(1):22-7. PubMed ID: 25162436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555.
    Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G
    Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-linolenic acid intake prevents endothelial dysfunction in high-fat diet-fed streptozotocin rats and underlying mechanisms.
    Zhang W; Fu F; Tie R; Liang X; Tian F; Xing W; Li J; Ji L; Xing J; Sun X; Zhang H
    Vasa; 2013 Nov; 42(6):421-8. PubMed ID: 24220118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabidiol improves vasorelaxation in Zucker diabetic fatty rats through cyclooxygenase activation.
    Wheal AJ; Cipriano M; Fowler CJ; Randall MD; O'Sullivan SE
    J Pharmacol Exp Ther; 2014 Nov; 351(2):457-66. PubMed ID: 25212218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with losartan and L-carnitine protects against endothelial dysfunction of streptozotocin-induced diabetic rats.
    Sleem M; Taye A; El-Moselhy MA; Mangoura SA
    Eur J Pharmacol; 2014 Dec; 744():10-7. PubMed ID: 25281836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired arachidonic acid-mediated dilation of small mesenteric arteries in Zucker diabetic fatty rats.
    Zhou W; Wang XL; Kaduce TL; Spector AA; Lee HC
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2210-8. PubMed ID: 15626691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and reversal of premature endothelial cell senescence and vasculopathy in obesity-induced diabetes by ebselen.
    Brodsky SV; Gealekman O; Chen J; Zhang F; Togashi N; Crabtree M; Gross SS; Nasjletti A; Goligorsky MS
    Circ Res; 2004 Feb; 94(3):377-84. PubMed ID: 14670841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AGE-breaker ALT-711 restores high blood flow-dependent remodeling in mesenteric resistance arteries in a rat model of type 2 diabetes.
    Freidja ML; Tarhouni K; Toutain B; Fassot C; Loufrani L; Henrion D
    Diabetes; 2012 Jun; 61(6):1562-72. PubMed ID: 22415880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of cardiovascular dysfunction associated with the metabolic syndrome and type 2 diabetes.
    Oltman CL; Kleinschmidt TL; Davidson EP; Coppey LJ; Lund DD; Yorek MA
    Vascul Pharmacol; 2008 Jan; 48(1):47-53. PubMed ID: 18164667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds.
    Wasan KM; Risovic V; Yuen VG; McNeill JH
    J Trace Elem Med Biol; 2006; 19(4):251-8. PubMed ID: 16443173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.